A photo of Stuart L. Goldstein.

Stuart L. Goldstein, MD, FAAP, FNKF

  • Clark D. West Endowed Chair
  • Director, Center for Acute Care Nephrology 
  • Medical Director, Pheresis Service
  • Co-Director, Heart Institute Research Core
  • Professor, UC Department of Pediatrics
Nephrology also allows me to practice across the entire spectrum of pediatric illness, from acute critical care, to chronic care and outpatient care.
Stuart L. Goldstein, MD, FAAP, FNKF



As a pediatric kidney specialist, I treat children and adolescents in all areas of pediatric nephrology. These include general nephrology, acute kidney injury (AKI), dialysis, transplantation and tuberous sclerosis. I also consult on fetal care if there is a problem with the unborn baby’s kidneys.

I was drawn to the field of nephrology by the opportunity it presents to improve the outcomes for children with kidney problems. Working with children and their families, I help patients reach their full potential. Nephrology also allows me to practice across the entire spectrum of pediatric illness, from acute critical care, to chronic care and outpatient care.

My research is focused on short- and long-term outcomes for children who have AKI and those who are at risk for AKI. I’m interested in AKI epidemiology and outcomes, acute renal replacement therapy and investigation of novel urinary AKI biomarkers in the pediatric population.

In 2012, I established Prospective Pediatric AKI Research Group (ppAKI-RG). The ppAKI-RG is comprised of more than 60 centers around the world with the goal of improving outcomes for the child with, or at-risk for, AKI. This consortium focuses on multicentered research studies that are dedicated to understanding and treating AKI in pediatric patients. This group has completed three major, unprecedented national and international studies to accurately characterize pediatric AKI epidemiology, reduce AKI and improve patient outcomes.

I also developed the only pediatric-specific, acute-care nephrology subspecialty fellowship with graduates who are now leaders in the field of pediatric AKI.

MD: Columbia College of Physicians and Surgeons, New York, NY, 1990.

Residency: Baylor College of Medicine, Houston, TX.

Fellowship: Pediatric Nephrology, Children's Hospital, Boston, MA.


Acute kidney injury; continuous renal replacement therapy; cardio-renal syndrome; nephrotoxic medication associated morbidity

Services and Specialties

Nephrology and Hypertension, Dialysis, End-Stage Renal Disease, Tuberous Sclerosis, Nephrology - Acute Care, Heart, Colorectal Disorders, Fontan Management


Acute kidney injury epidemiology and biomarkers; heart failure associated chronic kidney disease; nephrotoxic medication associated acute kidney injury reduction

Research Areas

Cardiology, Nephrology and Hypertension, Heart

Additional Languages


Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information


Serum renin and prorenin concentrations predict severe persistent acute kidney injury and mortality in pediatric septic shock. Stanski, NL; Pode Shakked, N; Zhang, B; Cvijanovich, NZ; Fitzgerald, JC; Jain, PN; Schwarz, AJ; Nowak, J; Weiss, SL; Allen, GL; et al. Pediatric Nephrology. 2023; 38:3099-3108.

Acute kidney injury biomarker olfactomedin 4 predicts furosemide responsiveness. Hasson, DC; Zhang, B; Krallman, K; Rose, JE; Kempton, KM; Steele, P; Devarajan, P; Goldstein, SL; Alder, MN. Pediatric Nephrology. 2023; 38:3153-3161.

Long-Term Healthcare Cost Savings of a Pediatric Nephrotoxic Medication-Associated Acute Kidney Injury Reduction Program in a Simulated Sample. Dynan, L; Lazear, D; Goldstein, SL. Journal of Pharmacy Practice. 2023; 36:795-802.

Overcoming Barriers to Drug Development in Children with CKD. Khurana, M; Egger, GF; Yao, L; Thompson, A; Pallidis, C; Goldstein, SL; Laskin, BL; Tuchman, S; Malley, MA; Uhlig, K. Clinical journal of the American Society of Nephrology : CJASN. 2023; 18:1101-1107.

Neonatal nephrotoxic medication exposure and early acute kidney injury: results from the AWAKEN study. Steflik, HJ; Charlton, JR; Briley, M; Selewski, DT; Gist, KM; Hanna, MH; Askenazi, D; Griffin, R; Sarkar, S; Kent, A; et al. Journal of Perinatology. 2023; 43:1029-1037.

Premature infants born <28 weeks with acute kidney injury have increased bronchopulmonary dysplasia rates. Starr, MC; Schmicker, RH; Halloran, BA; Heagerty, P; Brophy, P; Goldstein, SL; Juul, SE; Hingorani, S; Askenazi, DJ. Pediatric Research. 2023; 94:676-682.

Associations Between Characteristics of Individuals With Fontan Circulation With Blood and Urine Biomarkers of Kidney Injury and Dysfunction. Katz, DA; Gao, Z; Freytag, J; Mahendran, A; Szugye, C; Woodly, S; Alvarez, TC E; Lubert, AM; Alsaied, T; Goldstein, SL; et al. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease. 2023; 12:e029130.

Transdermal Detection of MB-102 and Correlation to Meropenem Pharmacokinetics During Continuous Renal Replacement Therapy: In Vivo Results. Dorshow, RB; Johnson, JR; Shieh, JJ; Riley, IR; Rogers, TE; Pino, CJ; Johnston, KA; Tang, P; Nolin, TD; Humes, HD; et al. ASAIO Journal. 2023; 69:708-715.

Do novel biomarkers have utility in the diagnosis and prognosis of acute kidney injury?: PRO. Kellum, JA; Goldstein, SL. 2023.

Acute kidney injury and early fluid load in a retrospective cohort of neonatal sepsis. Al Gharaibeh, FN; Mohan, S; Santoro, MA; Slagle, CL; Goldstein, SL. Pediatric Nephrology. 2023; 38:1971-1977.

From the Blog

First Acute Kidney Injury Diagnostic Test Wins FDA Clearance
Emergency and Critical Care

First Acute Kidney Injury Diagnostic Test Wins FDA Clearance

Stuart L. Goldstein, MD, FAAP, FNKF, Prasad Devarajan, MD12/7/2023

Better AWAREness of Acute Kidney Injury Could Transform Intensive Care
Emergency and Critical Care

Better AWAREness of Acute Kidney Injury Could Transform Intensive Care

Stuart L. Goldstein, MD, FAAP, FNKF6/30/2019

7 Things Parents Need To Know About Nephrotoxic Medications
Blog Rare and Complex Conditions

7 Things Parents Need To Know About Nephrotoxic Medications

By Stuart Goldstein, MD3/10/2016

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey

Overall Patient Rating